MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PHVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pharvaris (PHVS) Ownership - Who owns Pharvaris?

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
129
Web
https://www.pharvaris.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.31B
P/E Ratio
N/A
Total Cash
246.96M
Projected Growth
N/A
Total Debt
738.89K
Revenue
N/A
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
3.53
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PHVS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PHVS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
129
Web
https://www.pharvaris.com